FORTRESS MEDICARE LIMITED - Accounts


2017-02-01 2018-01-31 false Capium Accounts Production 1.1 10565120 bus:AbridgedAccounts 2017-02-01 2018-01-31 10565120 bus:FRS102 2017-02-01 2018-01-31 10565120 bus:AuditExemptWithAccountantsReport 2017-02-01 2018-01-31 10565120 bus:SmallCompaniesRegimeForAccounts 2017-02-01 2018-01-31 10565120 bus:PrivateLimitedCompanyLtd 2017-02-01 2018-01-31 10565120 2017-02-01 2018-01-31 10565120 2018-01-31 10565120 bus:RegisteredOffice 2017-02-01 2018-01-31 10565120 core:WithinOneYear 2018-01-31 10565120 core:AfterOneYear 2018-01-31 10565120 bus:Director1 2017-02-01 2018-01-31 10565120 bus:Director1 2018-01-31 10565120 bus:Director2 2017-02-01 2018-01-31 10565120 bus:Director2 2018-01-31 10565120 2016-02-01 10565120 bus:CompanySecretary1 2017-02-01 2018-01-31 10565120 bus:LeadAgentIfApplicable 2017-02-01 2018-01-31 10565120 2017-01-31 10565120 core:FurnitureFittings 2017-02-01 2018-01-31 10565120 core:FurnitureFittings 2018-01-31 10565120 core:FurnitureFittings 2017-01-31 10565120 core:ComputerEquipment 2017-02-01 2018-01-31 10565120 core:ComputerEquipment 2018-01-31 10565120 core:ComputerEquipment 2017-01-31 10565120 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2018-01-31 10565120 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2017-01-31 10565120 core:CostValuation core:Non-currentFinancialInstruments 2018-01-31 10565120 core:CostValuation core:Non-currentFinancialInstruments 2017-01-31 10565120 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2018-01-31 10565120 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2018-01-31 10565120 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2018-01-31 10565120 core:Non-currentFinancialInstruments 2018-01-31 10565120 core:Non-currentFinancialInstruments 2017-01-31 10565120 core:ShareCapital 2018-01-31 10565120 core:RetainedEarningsAccumulatedLosses 2018-01-31 10565120 dpl:Item1 2017-02-01 10565120 dpl:Item1 2018-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number : 10565120

 

 

 

FORTRESS MEDICARE LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 February 2017

End date: 31 January 2018
As described in the Statement of Financial Position you are responsible for the preparation of the financial statements for the year ended 31 January 2018 and you consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.



....................................................
LIGHTHALL CONSULT LTD
BOARDMAN HOUSE
64 BROADWAY
LONDON
E15 1NT
20 March 2018
1
 
 
Notes
 
2018
£
Fixed assets    
Tangible fixed assets 2 620 
620 
Current assets    
Cash at bank and in hand 14,238 
Creditors: amount falling due within one year (14,151)
Net current assets 87 
 
Total assets less current liabilities 707 
Net assets 707 
 

Capital and reserves
   
Called up share capital 100 
Profit and loss account 607 
Shareholders funds 707 
 


For the year ended 31 January 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The members have agreed to the preparation of abridged accounts.
Signed on behalf of the board of directors


--------------------------------
Babatunji ADEOGUN
Director

Date approved by the board: 20 March 2018
2
Statutory Information
FORTRESS MEDICARE LIMITED is a private limited company, limited by shares, domiciled in , registration number 10565120.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Financial Reporting Standard for Smaller Entities (effective January 2016).
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 25% Reducing Balance
Fixtures and Fittings 50% Reducing Balance
2.

Tangible fixed assets

Cost or Valuation Fixtures and Fittings   Computer Equipment   Total
  £   £   £
At 01 February 2017    
Additions 100    760    860 
Disposals    
At 31 January 2018 100    760    860 
Depreciation
At 01 February 2017    
Charge for year 50    190    240 
On disposals    
At 31 January 2018 50    190    240 
Net book values
Closing balance as at 31 January 2018 50    570    620 
Opening balance as at 01 February 2017 50    570    620 


3